The 14‐3‐3/SLP76 protein–protein interaction in T‐cell receptor signalling: a structural and biophysical characterization

The SH2 domain‐containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T‐cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14‐3‐3 adaptor proteins, which leads to...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	FEBS letters Ročník 595; číslo 3; s. 404 - 414
Hlavní autoři:	Soini, Lorenzo, Leysen, Seppe, Davis, Jeremy, Westwood, Marta, Ottmann, Christian
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.02.2021
Témata:	calorimetry crystal structure fluorescence immune response isothermal titration calorimetry phosphorylation protein constructs protein-protein interactions proteolysis surface plasmon resonance synthetic peptides T-lymphocytes TCR signalling and 14‐3‐3 titration X‐ray protein crystallography isothermal titration calorimetry protein constructs surface plasmon resonance TCR signalling and 14-3-3 X-ray protein crystallography
ISSN:	0014-5793, 1873-3468, 1873-3468
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	The SH2 domain‐containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T‐cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14‐3‐3 adaptor proteins, which leads to its proteolytic degradation. This provides a negative feedback mechanism by which TCR signalling can be controlled. To gain insight into the 14‐3‐3/SLP76 protein–protein interaction (PPI), we have determined a high‐resolution crystal structure of a SLP76 synthetic peptide containing Ser376 with 14‐3‐3σ. We then characterized its binding to 14‐3‐3 proteins biophysically by means of fluorescence polarization and isothermal titration calorimetry. Furthermore, we generated two recombinant SLP76 protein constructs and characterized their binding to 14‐3‐3. Our work lays the foundation for drug design efforts aimed at targeting the 14‐3‐3/SLP76 interaction and, thereby, TCR signalling.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0014-5793 1873-3468 1873-3468
DOI:	10.1002/1873-3468.13993